Pharsight

Drugs that contain Baclofen

1. Fleqsuvy patents expiration

Can you believe FLEQSUVY received compensation for the extended wait time during the regulatory approval process?
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11446246 AZURITY Suspensions and diluents for metronidazole and baclofen
Sep, 2037

(13 years from now)

US11324696 AZURITY Suspensions and diluents for metronidazole and baclofen
Sep, 2037

(13 years from now)

Market Authorisation Date: 04 February, 2022

Treatment: Indicated for the treatment of spasticity resulting from multiple sclerosis

Dosage: SUSPENSION;ORAL

How can I launch a generic of FLEQSUVY before it's drug patent expiration?
More Information on Dosage

FLEQSUVY family patents

Family Patents

2. Lyvispah patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10792262 AMNEAL Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives
Jul, 2039

(15 years from now)

US11654124 AMNEAL Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives
Jul, 2039

(15 years from now)

US11491125 AMNEAL Baclofen formulations and methods of minimizing patient exposure to metabolite variations
Sep, 2041

(17 years from now)

US11850225 AMNEAL Baclofen formulations and methods of minimizing patient exposure to metabolite variations
Sep, 2041

(17 years from now)

Market Authorisation Date: 22 November, 2021

Treatment: Method for treating spasticity; Treatment of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity; Treatment o...

Dosage: GRANULES;ORAL

More Information on Dosage

LYVISPAH family patents

Family Patents

3. Ozobax patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10610502 METACEL PHARMS LLC Oral baclofen solutions
Aug, 2039

(15 years from now)

Market Authorisation Date: 18 September, 2019

Treatment: Treatment of spasticity

Dosage: SOLUTION;ORAL

How can I launch a generic of OZOBAX before it's drug patent expiration?
More Information on Dosage

OZOBAX family patents

Family Patents